| Financial Year |
March 31 2023 |
| Monetary Funds |
294,452,854.86 |
| Held-for-trading Financial Assets |
59,767,998.00 |
| Notes Receivable |
149,869,324.73 |
| Accounts Receivable |
1,013,799,600.75 |
| Advances to Suppliers |
11,514,334.71 |
| Other Receivables |
26,358,862.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
728,452,738.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,424,666.98 |
| Total Current Assets |
2,313,773,726.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,794,977.31 |
| Investment Properties |
-- |
| Fixed Assetes |
361,282,380.42 |
| Under-construction Projects |
8,025,875.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,602,606.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,846,021.80 |
| Deferred Income Tax Assets |
96,023,210.86 |
| Other Non-Current Assets |
6,008,058.50 |
| Sub-Total of Non-Current Assets |
524,250,743.40 |
| Total Assets |
2,838,024,470.16 |
| Short-Term Loans |
541,921,261.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
61,235,513.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,644,220.14 |
| Taxes Payable |
12,185,049.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
413,125.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,205,469.98 |
| Other Current Liabilities |
24,351,977.43 |
| Sub-Total of Current Liabilities |
754,175,534.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,439,399.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,341,517.55 |
| Total Liabilities |
782,517,052.51 |
| Paid-In Capital(Or Share Stock) |
432,900,000.00 |
| Capital Surplus |
623,319,409.41 |
| Surplus Reserve |
86,942,584.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
879,868,754.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,055,507,417.65 |
| Owner's Equity（Stockholder's Equity） |
2,055,507,417.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,838,024,470.16 |
